Cobalt Inhibits the Interaction between Hypoxia-inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-α
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The hypoxia-inducible factor (HIF) activates the expression of genes that contain a hypoxia response element. The alpha-subunits of the HIF transcription factors are degraded by proteasomal pathways during normoxia but are stabilized under hypoxic conditions. The von Hippel-Lindau protein (pVHL) mediates the ubiquitination and rapid degradation of HIF-alpha (including HIF-1alpha and HIF-2alpha). Post-translational hydroxylation of a proline residue in the oxygen-dependent degradation (ODD) domain of HIF-alpha is required for the interaction between HIF and VHL. It has previously been established that cobalt mimics hypoxia and causes accumulation of HIF-1alpha and HIF-2alpha. However, little is known about the mechanism by which this occurs. In an earlier study, we demonstrated that cobalt binds directly to the ODD domain of HIF-2alpha. Here we provide the first evidence that cobalt inhibits pVHL binding to HIF-alpha even when HIF-alpha is hydroxylated. Deletion of 17 amino acids within the ODD domain of HIF-2alpha that are required for pVHL binding prevented the binding of cobalt and stabilized HIF-2alpha during normoxia. These findings show that cobalt mimics hypoxia, at least in part, by occupying the VHL-binding domain of HIF-alpha and thereby preventing the degradation of HIF-alpha.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“150 μM cobalt chloride, which blocks prolyl hydroxylation of HIF1α and its binding to VHL [41]”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [41]
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,897
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351
Cited by
Items 201–300 of 641
Osada-Oka, M., Hashiba, Y., Akiba, S., Imaoka, S., & Sato, T. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.046 · Cited by 43
Xu, M., Zhai, D., Xia, L., Li, H., Chen, S., Fang, B., Chang, J., & Wu, C. (2016) · Nanoscale · doi:10.1039/c6nr01952h · Cited by 42
Lin, T., Chou, C.-F., Chung, H., Chiang, C.-Y., Li, C., Wu, J., Lin, H. ‐., Pai, T., Hu, C., & Tzou, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101980 · Cited by 46
Kazi, A. A., Gilani, R. A., Schech, A. J., Chumsri, S., Sabnis, G. J., Shah, P., Goloubeva, O. G., Kronsberg, S. S., & Brodie, A. (2014) · Breast Cancer Research · doi:10.1186/bcr3609 · Cited by 43
“Third, investigation of HIF-1α protein stability after treatment with the protein synthesis inhibitor cycloheximide with or without the HIF-1α protein stabilizer CoCl2 [45], demonstrated that after addition of the protein synthesis inhibitor cycloheximide, HIF1α protein in vehicle-treated LTLTCa cells rapidly degraded…”
BackgroundYang, C., Wang, W., Chen, L., Liang, J., Lin, S., Lee, M.-Y., Ma, D., & Leung, C. (2016) · Chemical Communications · doi:10.1039/c6cc04938a · Cited by 42
García-Pastor, C., Martínez, S. B., Moreno‐Manzano, V., Fernández‐Martínez, A. B., & Lucio-Cazaña, F. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-52310-6 · Cited by 46
Unlocking mammalian regeneration through hypoxia inducible factor one alpha signaling
DeFrates, K. G., Franco, D., Heber‐Katz, E., & Messersmith, P. B. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120646 · Cited by 44
Hohensinner, P. J., Kaun, C., Rychli, K., Cohen, E. B.-T., Kastl, S., Demyanets, S., Pfaffenberger, S., Speidl, W. S., Rega‐Kaun, G., Ullrich, R., et al. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.043 · Cited by 42
Xu, Y.-Y., Liu, Y., Cui, L., Wu, W., Quinn, M. J., Menon, R., & Zhang, H. (2021) · Placenta · doi:10.1016/j.placenta.2021.09.003 · Cited by 41
Evaluation of Sirtuin Role in Neuroprotection of Retinal Ganglion Cells in Hypoxia
Balaiya, S., Ferguson, L. R., & Chalam, K. V. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-9259 · Cited by 41
Brucker, P. U., Izzo, N. J., & Chu, C. R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21346 · Cited by 47
Lin, H.-C., Su, S., Lu, C., Lin, A., Lin, W., Liu, C., Yang, Y., Wang, H.-M., Lii, C., & Chen, H. (2016) · Environmental Toxicology · doi:10.1002/tox.22293 · Cited by 40
“Although CoCl2 is a chemical hypoxia-mimetic agent by occupying the VHL-binding domain of HIF-1a and thereby preventing the degradation of HIF-1a (Yuan et al., 2003), it also acts as a pro-oxidant by increasing the levels of ROS in PC12 cells, most likely via a Fenton-type reaction (Wang et al.,…”
BackgroundEsser, T. U., Roshanbinfar, K., & Engel, F. B. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1561855 · Cited by 42
Xie, L., & Collins, J. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.489500 · Cited by 39
“Hypoxia can be mimicked by treating cells with cobalt chloride, which effectively inhibits proteasomal degradation of the HIF subunits under normoxic conditions (23, 24).”
BackgroundThe Impact of HIF1α on the Per2 Circadian Rhythm in Renal Cancer Cell Lines
Okabe, T., Kumagai, M., Nakajima, Y., Shirotake, S., Kodaira, K., Oyama, M., Ueno, M., & Ikeda, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109693 · Cited by 41
“CoCl2 treatment induces HIF1a expression by binding to the PAS domain, resulting in blockage of HIF1a-pVHL binding and thereby HIF1a stability [26,27].”
BackgroundWu, Y., Cao, Y., Liu, H., Yao, M., Ma, N., & Zhang, B. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03776-w · Cited by 44
A hazard evaluation of the reproductive/developmental toxicity of cobalt in medical devices
Monnot, A. D., Kovochich, M., Bandara, S. B., Wilsey, J. T., Christian, W. V., Eichenbaum, G. M., Perkins, L. E. L., Hasgall, P. A., Taneja, M., Connor, K. T., et al. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.104932 · Cited by 39
Ling, L., Feng, J., Wu, G., Wei, Z. C., Wang, J., Zhang, B., Liu, R., Liu, F., Wang, X., & Li, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416140 · Cited by 43
“CoCl2, which promotes the stabilization of HIF-1α [36,37], is commonly used as a drug for chemical hypoxia model of neurodegeneration [38].”
MethodLiu, Y., He, C.-Y., Yang, X.-M., Chen, W.-C., Zhang, M.-J., Zhong, X.-D., Chen, W.-G., Zhong, B.-L., He, S.-Q., & Sun, H.-T. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2350057x · Cited by 38
Deliormanlı, A. M., Vatansever, H. S., Sarsmaz, H. Y., & Özdal-Kurt, F. (2016) · Ceramics International · doi:10.1016/j.ceramint.2016.04.033 · Cited by 38
Merlo, S., Luaces, J. P., Spampinato, S. F., Toro-Urrego, N., Caruso, G. I., D’Amico, F., Capani, F., & Sortino, M. A. (2020) · Biomolecules · doi:10.3390/biom10030364 · Cited by 42
“In the present study, we used a previously established in vitro model of chemical hypoxia with CoCl2, which stabilizes the α subunit of the transcription factor HIF-1, dampening its degradation [59].”
MethodEndothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema
Pasupneti, S., Tian, W., Tu, A. B., Dahms, P. A., Granucci, E. J., Gandjeva, A., Xiang, M., Butcher, E. C., Semenza, G. L., Tuder, R. M., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0078oc · Cited by 40
He, S., Lu, G., Hou, H., Zhao, Z., Zhu, Z., Lu, X., Chen, J., & Wang, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2574 · Cited by 38
Wynn, M. L., Yates, J. A., Evans, C. R., Wassenhove, L. D. V., Wu, Z.-F., Bridges, S., Bao, L., Fournier, C. L., Ashrafzadeh, S., Merrins, M. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703959 · Cited by 39
“In contrast to the three cancer cell lines, the non-tumorigenic MCF10A cell line did not exhibit detectable levels of HIF-1 upon treatment with CoCl2, which was used to prevent the proteolytic degradation of HIF-1 (37) (Fig.”
BackgroundProlyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism
Nguyen, T.-L., & Durán, R. V. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.026 · Cited by 45
Kuehn, S., Hurst, J., Rensinghoff, F., Tsai, T., Grauthoff, S., Satgunarajah, Y., Dick, H. B., Schnichels, S., & Joachim, S. C. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.01.003 · Cited by 39
Hypoxia-inducible factor-1α suppresses the expression of macrophage scavenger receptor 1
Shirato, K., Kizaki, T., Sakurai, T., Ogasawara, J.-E., Ishibashi, Y., Iijima, T., Okada, C., Noguchi, I., Imaizumi, K., Taniguchi, N., et al. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0702-y · Cited by 43
“This prevents ubiquitin-dependent proteolysis of HIF-1α, resulting in promotion of the expression and nuclear translocation of HIF-1α protein without exposure to hypoxia [47, 49].”
BackgroundTrends in Natural Nutrients for Oxidative Stress and Cell Senescence
Omidifar, N., moghadami, M., Mousavi, S. M., Hashemi, S. A., Gholami, A., Shokripour, M., & Sohrabi, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7501424 · Cited by 36
HIF–prolyl hydroxylases and cardiovascular diseases
Banerjee, S. S., Thirunavukkarasu, M., Rishi, M. T., Sánchez, J. A., Maulik, N., & Maulik, G. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.673088 · Cited by 39
Song, H., Han, I., Kim, Y., Kim, Y. H., Choi, I., Seo, S., Jung, S. Y., Park, S., & Kang, M. S. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.02.004 · Cited by 36
“CoCl2 is the most frequently used chemical hypoxia-inducing agent, and it functions by stabilizing HIF1α [21,33,43].”
BackgroundMolitoris, K. H., Kazi, A. A., & Koos, R. D. (2009) · Endocrinology · doi:10.1210/en.2009-0884 · Cited by 38
HIF-1α Inhibition Reduces Nasal Inflammation in a Murine Allergic Rhinitis Model
Zhou, H., Chen, X., Zhang, W.-M., Zhu, L.-P., & Cheng, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048618 · Cited by 36
Sironval, V., Reylandt, L., Chaurand, P., Ibouraadaten, S., Palmai‐Pallag, M., Yakoub, Y., Učakar, B., Rose, J., Poleunis, C., Vanbever, R., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2188-x · Cited by 38
Chai, Y. C., Mendes, L. F., van Gastel, N., Carmeliet, G., & Luyten, F. P. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.048 · Cited by 37
Zheng, S., Bai, Y.-Y., Liu, Y., Gao, X., Li, Y., Changyi, Y., Wang, Y., Chang, D., Ju, S., & Li, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.006 · Cited by 37
The Disparate Roles of Cobalt in Erythropoiesis, and Doping Relevance
JELKMANN, W. E. B. (2012) · Open Journal of Hematology · doi:10.13055/ojhmt_3_1_6.121211 · Cited by 46
Iyer, S., Kannan, A., Gopal, A., Devaraj, N., & Devaraj, H. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.03.023 · Cited by 42
Coradini, D., Pellizzaro, C., Speranza, A., & Daidone, M. G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3324-0 · Cited by 37
Oehme, F., Jonghaus, W., Narouz-Ott, L., Hütter, J. F., & Flamme, I. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.066 · Cited by 40
Analysis of Hypoxia and Hypoxia-Like States through Metabolite Profiling
Gleason, J. E., Corrigan, D., Cox, J. E., Reddi, A. R., McGinnis, L. A., & Culotta, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024741 · Cited by 47
“In any case, Fe-S clusters can be added to the growing list of iron containing enzymes that are disrupted by cobalt, including the non-heme iron 2-oxoglutarate enzymes (hydroxylases for HIF-1a and the JmjC domain histone demethylases; [9,10,38]) and the diiron-oxo desaturases (Erg3p, Erg25p and Ole1p) described here.”
BackgroundSharma, N. M., Cunningham, C., Zheng, H., Liu, X., & Patel, K. P. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003423 · Cited by 38
Wojtal, K. A., Cee, A., Lang, S., Götze, O., Frühauf, H., Geier, A., Pastor‐Anglada, M., Torres‐Torronteras, J., Martí, R., Fried, M., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00353.2013 · Cited by 35
The hypoxic response and aging
Kaeberlein, M. R., & Kapahi, P. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9126 · Cited by 40
Jung, D., Kim, W., Seo, S., Oh, E., Yim, S., Ha, H., Chang, Y., & Williams, D. R. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.017 · Cited by 34
“To induce hypoxia, we used chemical treatment with cobalt chloride, which has been validated in previous studies (Wu and Yotnda, 2011; Yuan et al., 2003).”
MethodIshikawa, H., Xu, L., Sone, K., Kobayashi, T., Wang, G., & Shozu, M. (2018) · Reproductive Sciences · doi:10.1177/1933719118776793 · Cited by 34
Cryptochromes Suppress HIF1α in Muscles
Vaughan, M. E., Wallace, M., Handzlik, M. K., Chan, A. B., Metallo, C. M., & Lamia, K. A. (2020) · iScience · doi:10.1016/j.isci.2020.101338 · Cited by 36
Kovochich, M., Monnot, A. D., Kougias, D. G., More, S. L., Wilsey, J. T., Qiu, Q., Perkins, L. E. L., Hasgall, P. A., Taneja, M., Reverdy, E. E., et al. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.104910 · Cited by 34
Sakurai, T., Endo, S., Hatano, D., Ogasawara, J., Kizaki, T., Oh‐ishi, S., Izawa, T., Ishida, H., & Ohno, H. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02159.x · Cited by 43
“…in SVF cells It was recently demonstrated that transcription factor HIF-1a plays important roles in impeding the differentiation of preadipocytes (Yun et al. 2002, Lin et al. Values are mean SE. n = 40 (body mass, epididymal WAT mass/body mass and food intake) and n = 5 (adipocyte diameter and…”
BackgroundTürkoğlu, S. A., & KOCKAR, F. T. (2015) · Gene · doi:10.1016/j.gene.2015.08.035 · Cited by 34
Zhao, Y., Zheng, Y., Luo, Q., Yan, T., Liu, X. X., Han, L., & Zou, L. (2014) · Placenta · doi:10.1016/j.placenta.2014.04.002 · Cited by 35
Fadhillah, F., Yoshioka, S., Nishimura, R., Yamamoto, Y., Kimura, K., & Okuda, K. (2016) · Journal of Reproduction and Development · doi:10.1262/jrd.2016-068 · Cited by 39
Nunes, S. C., Lopes‐Coelho, F., Gouveia-Fernandes, S., Ramos, C., Pereira, S. A., & Serpa, J. (2018) · BMC Evolutionary Biology · doi:10.1186/s12862-018-1214-1 · Cited by 35
“Cobalt was shown to alter several systemic mechanisms related to hypoxia [31–33], namely the stabilization of hypoxia inducible factor alpha (HIF-α), thus preventing its degradation [34].”
BackgroundRibeiro, M. J., Maria, V. L., Soares, A. M. V. M., Scott-Fordsmand, J. J., & Amorim, M. J. B. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b02537 · Cited by 33
Nguyen, V. T., Canciani, B., Cirillo, F., Anastasia, L., Peretti, G. M., & Mangiavini, L. (2020) · Cells · doi:10.3390/cells9030757 · Cited by 35
“CoCl2 inhibits von Hippel–Lindau protein (pVHL) binding to oxygen degrading domain consisting of proline residues of HIF-1α thus preventing HIF-1α hydroxylation by oxygen-dependent prolyl hydroxylases (PHD) [1,26] whereas DMOG directly inhibits PHD leading to HIF-1α stability [27,28].”
BackgroundDiscovery of a new molecular probe ML228: An activator of the hypoxia inducible factor (HIF) pathway
Thériault, J. R., Felts, A. S., Bates, B. S., Perez, J. R., Palmer, M. A. J., Gilbert, S. R., Dawson, E. S., Engers, J. L., Lindsley, C. W., & Emmitte, K. A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.077 · Cited by 33
Zhang, X., Nan, K., Zhang, Y., Song, K., Geng, Z., Shang, D., Guan, X., & Fan, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129666 · Cited by 32
Yang, Y., CONG, H., Han, C., Yue, L., Dong, H., & Liu, J. (2015) · Oncology Reports · doi:10.3892/or.2015.4166 · Cited by 32
“Hypoxia-inducible factor-1α (HIF-1α) is a strong stimulator of neovascularization and excretion of VEGF at the transcription level (26-29).”
BackgroundHeiland, D. H., Gaebelein, A., Börries, M., Wörner, J., Pompe, N., Franco, P., Heynckes, S., Bartholomae, M., hAilín, D. Ó., Carro, M. S., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0680 · Cited by 37
Zeng, Q., Li, X., Li, J., Shi, M., Yao, Y., Guo, L., Zhi, N., & Zhang, T. (2024) · Advanced Science · doi:10.1002/advs.202400462 · Cited by 31
Mariani, V., Ponti, J., Giudetti, G., Broggi, F., Marmorato, P., Gioria, S., Franchini, F., Rauscher, H., & Rossi, F. (2011) · Nanotoxicology · doi:10.3109/17435390.2011.572302 · Cited by 32
Zhang, M., Zhang, W., Wu, Z., Liu, S., Sun, L., Zhong, Y., Zhang, X., Kong, X., Qian, P., Zhang, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6572 · Cited by 37
Paulin, F. V., Zagatto, A. M., Chiappa, G. R., & Müller, P. D. T. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.11.015 · Cited by 31
Atkinson, T. S., & Kahn, M. J. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100632 · Cited by 31
Yoon, S. A., Chun, J., Kang, C., & Lee, M. H. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01085 · Cited by 31
Zhao, K., Jiang, Y., Zhang, J., Shi, J., Zheng, P., Yang, C., & Chen, Y. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2087277 · Cited by 35
The mechanistic role of chemically diverse metal ions in the induction of autophagy
Sahni, S., Bae, D.-H., Jansson, P. J., & Richardson, D. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.009 · Cited by 31
“The chloride salt of another trace metal, cobalt, is a well-known hypoxia mimetic, which increases hypoxia-inducible factor-1 (HIF-1 ) levels in cells [103].”
BackgroundDeferroxamine Preconditioning Promotes Long-Lasting Retinal Ischemic Tolerance
Zhu, Y., Zhang, L., & Gidday, J. M. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0082 · Cited by 32
Lantin, A.-C., Mallants, A., Vermeulen, J., Speybroeck, N., Hoet, P., & Lison, D. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.12.003 · Cited by 31
“The erythropoietic action of cobalt is probably the result of its capacity to mimic the pathophysiological responses to hypoxia that involve hypoxia inducible factor 1 alpha (HIF-1alpha), leading to the induction of various genes, including those coding for erythropoiesis such as erythropoietin (EPO) (Chun et al., 200…”
BackgroundNADPH oxidase 4 mediates TGF-β1/Smad signaling pathway induced acute kidney injury in hypoxia
Cho, S.-K., Yu, S., Kang, J., Jeong, B. Y., Lee, H. Y., Park, C. G., Yu, Y.-B., Jin, D. C., Hwang, W.-M., Yun, S.-R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219483 · Cited by 37
Hong, J. S., Medzikovic, L., Sun, W., Wong, B., Ruffenach, G., Rhodes, C. J., Brownstein, A. J., Liang, L. L., Aryan, L., Li, M., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.069864 · Cited by 36
Attenuation of Choroidal Neovascularization by Histone Deacetylase Inhibitor
Chan, N., He, S., Spee, C. K., Ishikawa, K., & Hinton, D. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120587 · Cited by 31
Detrimental effects of hypoxia on glomerular podocytes
Singh, A., Kolligundla, L. P., Francis, J., & Pasupulati, A. K. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00788-y · Cited by 30
The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis
Wang, H., Wang, L., Li, Y., Luo, S., Ye, J., Lu, Z., Li, X., & Lu, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111778 · Cited by 30
Caltana, L. R., Rutolo, D., Nieto, M. L., & Brusco, A. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.09.011 · Cited by 32
“This in turn produces a focal hypoxia-like lesion by stabilizing and inducing HIF-1a and exhibiting neuronal and glial alterations (Caltana et al., 2009).”
A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases
Cho, H.-J., Park, H., & Yang, E. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.041 · Cited by 29
Sp1‐dependent regulation of the tissue inhibitor of metalloproteinases‐1 promoter
Lee, M., Song, S. U., Ryu, J., & Suh, J. K. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20021 · Cited by 32
“It was previously reported that cobalt ion has the same physiological effect as hypoxia [Maxwell et al., 1993;WangandSemenza, 1993; Jiang et al., 1997; An et al., 1998; Chandel et al., 1998; Minchenko and Caro, 2000; Wang et al., 2000; Piret et al., 2002; Yuan et al., 2003].”
BackgroundTransition metals in angiogenesis – A narrative review
Dürig, J., Calcagni, M., & Buschmann, J. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100757 · Cited by 35
A comparative immunological analysis of CoCl2 treated cells with in vitro hypoxic exposure
., S., Mishra, K. P., Chanda, S., Singh, S. B., & Ganju, L. (2014) · BioMetals · doi:10.1007/s10534-014-9813-9 · Cited by 31
Colijn, S., Gao, S., Ingram, K. G., Menendez, M. T., Muthukumar, V., Silasi‐Mansat, R., Chmielewska, J. J., Hinsdale, M. E., Lupu, F., & Griffin, C. T. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0376-8 · Cited by 27
Liu, J., Zou, T., Yao, Q., Zhang, Y., Zhao, Y. D., & Zhang, C. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111797 · Cited by 28
Yong, J., von Bremen, J., Groeger, S. E., Ruiz‐Heiland, G., & Ruf, S. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16920 · Cited by 28
Shao, Y.-L., Li, Y.-Q., Li, M., Wang, L., Zhou, H.-S., Liu, D., Yu, L., Lin, J., & Gao, X. (2023) · Leukemia · doi:10.1038/s41375-023-01904-1 · Cited by 28
Gariboldi, M. B., Taìana, E., Bonzi, M. C., Craparotta, I., Giovannardi, S., Mancini, M., & Monti, E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.008 · Cited by 31
“Increased degradation through the canonical pathway can be ruled out under conditions where O2 is depleted or PHD activity is directly inhibited by CoCl2 [30]; and the observation that HIF-2α (undergoing the same normoxic degradation pathway)”
BackgroundMethodThe hypoxia-mimetic agent CoCl2 induces chemotherapy resistance in LOVO colorectal cancer cells
YANG, G., XU, S., PENG, L., Li, H., Zhao, Y., & Hu, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4836 · Cited by 30
Coviello, V., Marchi, B., Sartini, S., Quattrini, L., Marini, A. M., Simorini, F., Taliani, S., Salerno, S., Orlandi, P., Fioravanti, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00616 · Cited by 30
Kaluz, Š., Kaluzová, M., & Stanbridge, E. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21644 · Cited by 31
“This led to alternative theories, e.g., Co(II) may stabilize HIF-1 a by coordinating carboxylate residues close to P564 [Yuan et al., 2003] or that Co(II) and Ni(II) deplete intracellular ascorbate levels [Salnikow et al., 2004].”
BackgroundInfluentialNakuluri, K., Mukhi, D., Mungamuri, S. K., & Pasupulati, A. K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28041 · Cited by 31
Diminished apoptosis in hypoxic porcine retina explant cultures through hypothermia
Maliha, A. M., Kuehn, S., Hurst, J., Herms, F., Fehr, M., Bartz‐Schmidt, K. U., Dick, H. B., Joachim, S. C., & Schnichels, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-41113-4 · Cited by 29
Chao, A., Chen, C.-H., Wu, M.-H., Hou, B.-Y., & Yang, D. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118628 · Cited by 27
Conditions for maintenance of hepatocyte differentiation and function in 3D cultures
Handin, N., Mickols, E., Ölander, M., Rudfeldt, J., Blom, K., Nyberg, F., Senkowski, W., Urdzik, J., Maturi, V., Fryknäs, M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103235 · Cited by 32
CD47-Dependent Regulation of H2S Biosynthesis and Signaling in T Cells
Kaur, S., Schwartz, A. L., Miller, T. W., & Roberts, D. D. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2014.11.023 · Cited by 29
Mattia, M. D., Mauro, A., Monache, S. D., Pulcini, F., Russo, V., Berardinelli, P., Citeroni, M. R., Turriani, M., Peserico, A., & Barboni, B. (2022) · Cells · doi:10.3390/cells11030461 · Cited by 32
“Using such a mechanism, CoCl2 artificially induces hypoxia by blocking HIF1α degradation and favouring protein accumulation [35].”
BackgroundCobalt Chloride Enhances the Stemness of Human Dental Pulp Cells
Laksana, K., Sooampon, S., Pavasant, P., & Sriarj, W. (2017) · Journal of Endodontics · doi:10.1016/j.joen.2017.01.005 · Cited by 27
Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_11 · Cited by 34
Solanki, A. K., Autefage, H., Rodriguez, A. R., Agarwal, S., Penide, J., Mahat, M., Whittaker, T. E., Nommeots‐Nomm, A., Littmann, E., Payne, D. J., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1125060 · Cited by 26
“Cobalt is known to stabilise HIF-1α (Yuan et al., 2003) and has been recently incorporated into wound dressings (Shi et al.”
BackgroundBredow, S., Falgout, M. M., March, T. H., Yingling, C. M., Malkoski, S. P., Aden, J. K., Bedrick, E. J., Lewis, J. L., & Divine, K. K. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.03.010 · Cited by 28
“It is known that hypoxic conditions cause a rapid accumulation of HIF-1α without affecting the mRNA level (Yuan et al., 2003).”
BackgroundMarques, A. P., Rosmaninho‐Salgado, J., Estrada, M. F., Cortez, V., Nobre, R. J., & Cavadas, C. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.12.005 · Cited by 30
Rani, A., & Prasad, S. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1388-x · Cited by 26
Alterations in Blood Components
Carter, C. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64251-4 · Cited by 40
Schoos, A., Gabriel, C., Knab, V. M., & Fux, D. A. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257501 · Cited by 24
“As a positive control, cells were incubated with 100 mMCoCl2 for 3 hours (Yuan et al., 2003).”
Method
Metadata
- Authors
- Yuan, Y., Hilliard, G., Ferguson, T., & Millhorn, D. E.
- Affiliations
- University of Cincinnati (US)
- Corresponding author
- Millhorn, David E.
- ORCID
- Yuan, Yong
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 18
- Pages
- 15911-15916
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2120090919
- Cited by
- 638
- References
- 23
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 26 · 2023: 24 · 2022: 45 · 2021: 35 · 2020: 34 · 2019: 36 · 2018: 29 · 2017: 36 · 2016: 34 · 2015: 32 · 2014: 37 · 2013: 23 · 2012: 31
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6378 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl059945-09)
- National Heart, Lung, and Blood Institute (HL-33831, HL-59945)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- cobalt, hypoxia-inducible factor alpha, von Hippel-Lindau protein, HIF-2α, oxygen-dependent degradation domain, HIF stabilization, ubiquitination, proteasomal degradation, proline hydroxylation
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Amino Acid Sequence, Animals, Cobalt, Deferoxamine, Glycine, Cricetinae, Hydroxylation, Ligases, Molecular Sequence Data, Transcription Factors, Trans-Activators, CHO Cells, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Rats, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.